Radiotherapy of bronchogenic carcinoma. Analysis of a treatment schedule designed for use with hyperbaric oxygen.

Abstract
All cases of bronchogenic carcinoma treated with curative intent over an 8 yr period were reviewed. Most were treated with 12 .times. 400 rad in 32 days using 60Co, a schedule designed to optimize the radiation-sensitizing properties of hyperbaric oxygen. While O2 gave no obvious benefit, overall 4 yr survival was 10.6%; that of patients with good prognostic indicators was 18%. No radiation myelitis was observed. This protocol delivers an adequate tumor dose and appears to be tolerated well by most patients.